What tirzepatide side effects should I actually worry about?
Most side effects are GI and manageable with slow dose titration. The ones that matter clinically: pancreatitis (rare but serious), medullary thyroid carcinoma risk if personal or family history, severe gastroparesis, and lean-mass loss if you do not intervene on protein and training.
What you will probably experience
Nausea, fullness, constipation, occasional diarrhea, and mild reflux. In SURMOUNT-1 roughly 24 to 31 percent reported nausea at some point. These peak during dose step-ups (week 5, 9, 13, etc.) and usually resolve within a week. Manage by eating smaller meals, avoiding fat-heavy food for the first few days after a step-up, and staying hydrated.
What genuinely matters
Pancreatitis is the most serious reported adverse event. Incidence is rare (~1 in 500 to 1 in 1,000 user-years) but it is why a history of pancreatitis is a contraindication. Medullary thyroid carcinoma (MTC) risk is why personal or family history of MTC or multiple endocrine neoplasia type 2 is also a hard contraindication. Severe gastroparesis pre-existing is a flag. Suicidal ideation has been reported in a small fraction of users on GLP-1 class drugs; if you have a history, tell your prescriber.
What the marketing skips
Lean-mass loss is a real side effect, not just a nutrition topic. Without intervention, you lose roughly 25 percent of your weight as lean mass. Over 72 weeks this is meaningful. The protocol to prevent it is protein intake of 1.6 to 2.2 g/kg target weight and 2 to 3 resistance training sessions per week. Not optional.
The answer for your situation.
The answer above is the general case. The match for your specific profile, region, budget, and urgency comes from our 2-minute quiz. One email, your match, no list.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.